POST Online Media Lite Edition


Intercept Pharma names SVP, head of Europe

Staff writer |
New York, N.Y., USA - November 18, 2014, New York, N.Y., USA - Intercept Pharmaceuticals, a clinical stage biopharmaceutical company, announced the appointment of Lisa Bright as senior vice president and head of Europe.

Ms. Bright will be a member of the Intercept senior management team. A seasoned executive who brings more than 25 years of biotech and pharmaceutical industry experience, Ms. Bright comes to Intercept from Gilead Sciences where she held positions of increasing responsibility, including Vice President, Northern Europe, and most recently Vice President, Head of Sovaldi Launch Planning for Europe, Asia, Middle East and Australasia and Vice President, Head Government Affairs for Europe, Middle East and Australasia.

Ms. Bright's leadership of Sovaldi's European launch contributed to the most successful product launch in pharmaceutical history. Ms. Bright joined Gilead as General Manager, UK & Ireland in 2008.


What to read next

NightstaRx appoints Senthil Sundaram as CFO
Intercept Pharma appoints Sandip Kapadia as CFO
IOmet Pharma appoints Rakesh Patel as non-executive director